Introduction {#s1}
============

Previous studies have reported that short sleep durations are associated with increased risks of mortality from stroke.[@R1] In addition to short sleep duration, sleep quality may also play a role in disease aetiology.[@R3] However, few studies have explored the effects of insomnia on stroke mortality.[@R4]

Insomnia, affecting approximately 12%--57% of stroke survivors, plays an essential role in the prognosis after stroke.[@R5] Indeed, poststroke insomnia may have significant deleterious effects. Some studies have reported links between poststroke insomnia and more significant disabilities, including increased risk of subsequent stroke.[@R7] Moreover, poststroke insomnia can worsen poststroke depression,[@R9] which decreased outcomes of stroke.[@R10] Although previous studies have reported detrimental effects of insomnia, the diagnositic criteria of insomnia in those studies were not unified.[@R11]

Recurrence of stroke is common among stroke survivors with cumulative disability. Furthermore, patients with recurrent stroke have a 43% higher risk of dying than survivors with the first-ever stroke.[@R12] However, previous studies have failed to distinguish the effect of recurrence when studying the relationship between sleep and mortality.

The current study aimed to examine the association between insomnia and mortality in the first-ever stroke in the Chinese population.

Materials and methods {#s2}
=====================

Patients and study settings {#s2a}
---------------------------

This was a 6-year follow-up study of patients with stroke. The baseline data were from a study titled 'Prospective Cohort Study on the Incidence and Outcome of Patients with Post-stroke Depression in China (PRIOD)'.[@R13] In this study, patients with stroke from 56 neurology departments were recruited between April 2008 and April 2010. Patients aged 18 years or older, whose conditions were confirmed by CT or MRI within 14 days of clinical presentation, were recruited based on the WHO criteria for stroke.[@R14] The patients provided written informed consent and agreed to follow up.

Demographic data (age, gender, living condition, education, marital status and personal characteristics) were collected at intake time. Medical history, past psychiatric diagnosis, vascular risk factors (eg, history of hypertension, diabetes and smoking), clinical characteristics such as type of stroke and National Institute of Health Stroke Scale (NIHSS) score for the first time after admission, and other medical complications (eg, atrial fibrillation, urinary disease and tumours) were also collected at intake time. Exclusion criteria were patients who had a history of stroke; patients with obvious aphasia that impeded the patient from finishing psychological assessment; patients who withdrew from follow-up at any of the following time points; and patients with severe heart disease or nephropathy or tumour, or a history of psychiatric diagnosis, as the above conditions were shown to be associated with insomnia and mortality.[@R15]

The study was conducted in compliance with the Declaration of Helsinki guidelines for the protection of human subjects.

Measurement and evaluation {#s2b}
--------------------------

In this study, clinical physiologists who were responsible for the follow-up at each centre received systematic training on clinical assessment tools and diagnostic criteria.

Follow-up assessments included the diagnosis of depression based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV),[@R17] and assessment of the Hamilton Rating Scale for Depression (17 items, HRSD-17) at day 14±2, 3 and 6 months, and day 360±7 poststroke.[@R18] Stroke severity was assessed at baseline using the NIHSS.

Ascertainment of stroke mortality {#s2c}
---------------------------------

All deaths were identified from the local Disease Surveillance Points system death registries. The causes of death were coded according to the 10th International Classification of Diseases. Duration of follow-up was calculated from the time of the baseline evaluation to the date of death.

Definition of insomnia {#s2d}
----------------------

Insomnia was ascertained using three items from the HRSD-17, consisting of the core symptoms of insomnia in DSM-IV.[@R17] These three questions are the following: (1)'Have you experienced difficulty falling asleep?' (2)'Have you experienced difficulty staying asleep?' and (3) 'Have you experienced waking up early and not being able to sleep again?' Participants were classified as having insomnia if they reported experiencing one or more sleep conditions for at least three nights a week. Patients were classified as having insomnia if they reported experiencing one or more of the above items at two consecutive visits. The two successive follow-up times were at least 3 months or 6 months.

Definition of baseline {#s2e}
----------------------

Demographic characteristics, vascular risk factors and clinical characteristics were defined as the baseline in this study at intake time. Sleep factors of HRSD-17 in the four assessments during the first year were used to determine whether the patient had insomnia.

Statistical analysis {#s2f}
--------------------

Statistical analyses were conducted using the Statistical Analysis System (SAS) V.9.2 software. Continuous data are expressed as median (IQR). Discrete data are expressed as frequencies and percentiles. The χ^2^ test or Fisher's test was used for analysis. Group differences of continuous data and one-way orderly data were analysed using the Wilcoxon rank-sum test. Cox proportional hazard regressions were used to calculate HRs and their 95% CIs. For all analyses, a two-tailed probability value of P*\<*0.05 was considered statistically significant.

Results {#s3}
=======

Comparison between patients enrolled and not enrolled {#s3a}
-----------------------------------------------------

Among 1273 patients with first-ever stroke, 16.6% (211) were excluded from the analyses due to incomplete follow-up, and 1062 patients with first-ever stroke who met the inclusion criteria were enrolled in the study ([figure 1](#F1){ref-type="fig"}). No significant differences were found between patients enrolled (n=1062) and those not enrolled (n=211) ([table 1](#T1){ref-type="table"}).

![Flow chart of the participant selection.](svn-2017-000136f01){#F1}

###### 

Comparison of characteristics between patients enrolled in the study and those who withdrew from the follow-up

  Variables                                       Enrolled (n=1062)   Withdrew (n=211)   P value
  ----------------------------------------------- ------------------- ------------------ ---------
  Demographic characteristics                                                            
   Age, year, mean±SD                             60.47±11.57         60.60±12.90        0.88
   Female, n (%)                                  364 (34.3)          72 (34.1)          0.97
   Education level                                                                       
    High school and above, n (%)                  762 (71.8)          150 (71.1)         0.85
   Married, n (%)                                 992 (93.4)          193 (91.9)         0.43
   Living alone, n (%)                            1037 (97.6)         204 (96.7)         0.41
   Employed, n (%)                                502 (47.4)          96 (45.5)          0.60
   Family history of mental disease, n (%)        187 (18.2)          40 (19.9)          0.56
  Vascular risk factors                                                                  
   Smoker, n (%)                                  483 (45.7)          97 (46.2)          0.90
   Hypertension, n (%)                            708 (67.9)          142 (69.6)         0.77
   Diabetes, n (%)                                225 (21.6)          39 (18.8)          0.38
   Hyperlipidaemia, n (%)                         178 (19.1)          40 (22.1)          0.35
  Clinical characteristics                                                               
   Diagnosis of ISH, n (%)                        863 (81.3)          164 (77.7)         0.24
   NIHSS score at 14±2 days, mean±SD              4.62±4.03           4.62±4.03          0.07
   Stroke recurrence at 1-year follow-up, n (%)   65 (7.1)            11 (5.2)           0.61
   Death at 6-year follow-up, n (%)               130 (12.2)          35 (16.6)          0.40

Smoker, with or without a history of smoking.

ISH, ischaemic stroke; NIHSS score, the first National Institutes of Health Stroke Scale.

Demographic and clinical characteristics of patients with insomnia and without insomnia {#s3b}
---------------------------------------------------------------------------------------

Among 1062 patients included in the analyses, 489 (38.4%) met the diagnosis of insomnia in the first-year follow-up, 132 (15.5%) suffer from one kind of insomnia listed above, while 356 (33.9%) suffer from mixed features, and 130 (9.4%) patients died. The group of patients with insomnia had significantly higher NIHSS score (5.21±4.38 vs 4.12±3.65, P\<0.001), more female patients (39.9% vs 29.5%, P\<0.001) and higher rate of depression (54.8% vs 20.8%, P*\<*0.001) at baseline assessment ([table 2](#T2){ref-type="table"}). Moreover, patients with insomnia had a significantly higher recurrence rate of stroke (8.2% vs 4.4%, P=0.02) during the first-year follow-up and had significantly higher mortality (15.1% vs 9.7%, P=0.008) at 6-year follow-up than those without insomnia. No other significant differences were found between the two groups.

###### 

Demographic and clinical characteristics of the study population at baseline

  Variables                                       All patients   Groups                    
  ----------------------------------------------- -------------- ------------ ------------ ---------
  Demographic characteristics                                                              
   Age, year, mean±SD                             60.47±11.57    48.9±46.0    57.3±54.0    0.08
   Female, n (%)                                  364 (34.3)     195 (39.9)   169 (29.5)   \<0.001
   Education level, n (%)                                                                  
    High school and above, n (%)                  762 (72.0)     351 (71.8)   411 (72.1)   0.25
   Married, n (%)                                 992 (93.5)     456 (93.3)   536 (93.5)   0.90
   Living alone, n (%)                            25 (2.4)       9 (1.84)     16 (2.8)     0.42
   Employed, n (%)                                502 (47.4)     215 (44.1)   287 (50.4)   0.04
   Family history of mental disease, n (%)        188 (18.3)     87 (18.2)    101 (18.3)   1.0
  Vascular risk factors                                                                    
   Smoker, n (%)                                  483 (45.7)     216 (44.3)   267 (46.9)   0.42
   Hypertension, n (%)                            708 (67.9)     321 (66.7)   387 (68.9)   0.47
   Diabetes, n (%)                                224 (21.5)     105 (21.9)   119 (21.2)   0.82
   Hyperlipidaemia, n (%)                         179 (19.0)     80 (18.3)    99 (19.8)    0.62
  Clinical characteristics                                                                 
   Diagnosis of ISH, n (%)                        863 (81.3)     383 (78.3)   480 (83.8)   0.02
   NIHSS score at 14±2 day, mean±SD               4.62±4.03      5.21±4.4     4.12±3.7     \<0.001
   Depression at 1-year follow-up, n (%)          387 (36.4)     268 (54.8)   119 (20.8)   \<0.001
   Stroke recurrence at 1-year follow-up, n (%)   65 (6.1)       40 (8.2)     25 (4.4)     0.02
   Death at 6-year follow-up, n (%)               130 (12.2)     74 (15.1)    56 (9.7)     0.008

Smoker, with or without a history of smoking.

ISH, ischaemic stroke; NIHSS score, the first National Institutes of Health Stroke Scale.

Univariate analysis and multivariate model of death and survivors {#s3c}
-----------------------------------------------------------------

Death within 6 years was associated with old age (69.7±11.0 vs 59.2±11.0, P=0.000), higher rate of insomnia (56.9% vs 44.5%, P=0.01), higher recurrence rate of stroke (14.6% vs 5.0%, P=0.000) during the first year of follow-up, lower education (58.5% vs 73.6%, P=0.000), lower employment rate (21.5% vs 51.2%, P=0.000) and higher rate of hypertension (76.2% vs 66.7%, P=0.03) ([table 3](#T3){ref-type="table"}). The multivariate Cox regression analysis revealed that age (HR=1.08, 95% CI 1.06 to 1.10), stroke recurrence in the first-year follow-up (HR=2.53, 95% CI 1.48 to 4.31), insomnia (HR=1.66, 95% CI 1.10 to 2.48; [figure 2](#F2){ref-type="fig"}) and hypertension (HR=1.62, 95% CI 1.04 to 2.53) were significantly associated with death at 6-year follow-up ([table 4](#T4){ref-type="table"}).

###### 

Demographic and clinical characteristics of the study population at baseline

  Variables                                               All patients   Groups                    
  ------------------------------------------------------- -------------- ------------ ------------ -------
  Demographic characteristics                                                                      
   Age, year, mean±SD                                     60.47±11.57    69.7±11.0    59.2±11.0    0.00
   Female, n (%)                                          364 (34.3)     51 (39.2)    313 (33.6)   0.20
   Education level, n (%)                                                                          
    High school and above, n (%)                          762 (71.8)     76 (58.5)    686 (73.6)   0.00
   Married, n (%)                                         992 (93.4)     118 (90.8)   874 (93.8)   0.20
   Living alone, n (%)                                    25 (2.4)       6 (4.6)      19 (2.0)     0.07
   Employed, n (%)                                        502 (47.5)     28 (21.5)    474 (51.2)   0.00
   Family history of mental disease, n (%)                188 (18.3)     15 (12.3)    173 (19.1)   0.07
  Vascular risk factors                                                                            
   Smoker, n (%)                                          483 (45.7)     45 (35.2)    438 (47.2)   0.01
   Hypertension, n (%)                                    708 (67.9)     99 (76.2)    614 (66.7)   0.03
   Hyperlipidaemia, n (%)                                 179 (19.1)     17 (14.8)    162 (19.8)   0.20
   Diabetes, n (%)                                        224 (21.5)     33 (26.2)    191 (20.9)   0.17
  Clinical characteristics                                                                         
   Diagnosis of ISH, n (%)                                863 (81.3)     111 (78.3)   752 (85.4)   0.21
   NIHSS score at 14±2 days, mean±SD                      4.62±4.03      5.23±4.0     4.54±4.0     0.07
   Depression at 1-year follow-up, n (%)                  387 (36.4)     49 (37.7)    338 (36.3)   0.75
   Stroke recurrence at 1-year follow-up, n (%)           65 (6.1)       19 (14.6)    47 (5.0)     0.00
   Insomnia, n (%)                                        489 (46.0)     74 (56.9)    415 (44.5)   0.01
   Difficulty falling asleep, n (%)                       69 (6.5)       14 (10.8)    55 (5.9)     0.04
   Difficulty staying asleep, n (%)                       19 (4.8)       7 (5.4)      12 (1.3)     0.001
   Waking up early, n (%)                                 44 (4.2)       6 (4.6)      38 (4.2)     0.82
   Difficulty falling asleep and staying asleep, n (%)    52 (4.9)       7 (5.4)      45 (4.8)     0.78
   Difficulty falling asleep and waking up early, n (%)   73 (6.9)       10 (7.7)     63 (6.8)     0.69
   Difficulty staying asleep and waking up early, n (%)   24 (2.3)       3 (2.3)      21 (2.3)     0.97
   All of the three, n (%)                                208 (19.8)     27 (21.5)    181 (19.5)   0.59

Smoker, with or without a history of smoking.

ISH, ischaemic stroke; NIHSS score, the first National Institutes of Health Stroke Scale.

###### 

Risk factors associated with death in the Cox regression among the first-ever stroke survivors

  Factors                                 HR     95% CI         P value
  --------------------------------------- ------ -------------- ---------
  Age                                     1.08   1.06 to 1.10   0.000
  Insomnia                                1.66   1.10 to 2.48   0.01
  Sex                                     1.20   0.73 to 1.88   0.45
  Smoking                                 0.97   0.63 to 1.51   0.90
  Marital status                          1.37   0.59 to 3.15   0.45
  Living arrangement                      0.63   0.21 to 1.90   0.42
  Depression                              0.89   0.59 to 1.35   0.58
  Illiteracy                              1.78   0.97 to 3.72   0.45
  Primary education                       0.83   0.51 to 1.36   0.62
  Hypertension                            1.62   1.04 to 2.53   0.04
  Hyperlipidaemia                         0.71   0.42 to 1.21   0.21
  Diabetes mellitus                       1.27   0.82 to 1.98   0.29
  Diagnoses                               0.94   0.55 to 1.61   0.82
  Stroke recurrence at 1-year follow-up   2.53   1.48 to 4.31   0.001
  NHISS score                             1.03   0.98 to 1.08   0.21

Smoking status, with or without a history of smoking. Diagnoses include ischaemic stroke and haemorrhagic stroke.

NIHSS, the first National Institutes of Health Stroke Scale.

![Kaplan-Meier survival curves by insomnia status at 6-year follow-up.](svn-2017-000136f02){#F2}

Discussion {#s4}
==========

So far as is known, this is the first prospective cohort study in China to investigate the relationship between insomnia and mortality in patients with first-ever stroke. The result demonstrated that insomnia was associated with a 1.66-fold increase in the risk of death at 6-year follow-up. The prevalence of insomnia was 38.4%, consistent with the range (12%--57%) reported by other Western researchers.[@R5]

This research adjusted many possible confounders, especially depression, as comorbidity, which was evaluated during the first-year follow-up. The association between insomnia and mortality was not essentially changed by depression.[@R1] Also, the result concluded that old age and recurrent stroke within the first year were statistically the most important risk factors for mortality.[@R22] The NIHSS scores were significantly more associated with insomnia, while these were not associated with mortality at 6-year follow-up. This result was consistent with another study by Luo *et al* [@R24], which exhibited that high NIHSS scores before treatment were associated with mortality at 90 days.

Linking insomnia to mortality had been extensively studied by other research groups[@R25]; however, no research has explored the relationship between insomnia and poststroke mortality. This finding showed that insomnia was significantly associated with the increase in mortality. Also, the definition of insomnia in this study stimulated to the diagnostic criteria of insomnia in the DSM-IV. Occurrence of sleep disturbance despite adequate opportunity and circumstances for sleep is required to diagnose insomnia,[@R26] and the participants in this study were discharged from the hospital and met the standard. Furthermore, this study ruled out new tumours, severe heart failure and severe kidney disease, which may be linked to sleep deprivation and further impaired neuropsychological performance.[@R27]

This study found that stroke survivors with hypertension had a substantially higher risk of mortality (HR=1.61, 95% CI 1.04 to 2.53), and this result is consistent with previous investigations that showed that blood pressure and blood pressure variability were each associated with poor outcome.[@R2] Some previous studies suggested that insomnia can lead to hypertension by activating the sympathetic system,[@R30] impairing sleep quality, as well as decreasing insulin sensitivity and glucose tolerance.[@R32] Hypertension and diabetes are thought to contribute to higher cardiovascular mortality risk. Extensive research has proved that insomnia increases the risk of mortality in patients with cardiovascular disease (CVD).[@R3] Consequently, these two conditions might partly mediate the association between insomnia and death. Some studies found that patients with stroke who also had CVD or kidney dysfunction had a higher risk of death.[@R15] In this study, subjects with severe physical illness were excluded, which might explain the weak statistical power of the result.

Strengths of this study are its large sample size, first-ever stroke and extended follow-up. There are several limitations to the present study that should be noted. First, the definition of insomnia in this study was similar to the diagnostic criteria of insomnia in the DSM-IV, and it qualified in every diagnostic criterion. Second, there are no statistics on the use of hypnotics in this study. Third, this study only included several potential confounding factors.

In summary, insomnia, old age, stroke recurrence in the first-year follow-up and hypertension were high-risk factors for mortality over 6 years of follow-up in the large sample of patients with first-ever stroke. Participants with insomnia suffered a higher recurrence of stroke during the first year of follow-up. Whether prompt and efficient interventions for insomnia can decrease mortality in patients with first-ever stroke is still ambiguous. More studies are expected in the future.
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